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Welcome to the first issue of The California Journal of
Emergency Medicine.  This journal is a quarterly journal
dedicated to providing CAL-AAEM and other physicians up-to-
date information on the practice of emergency medicine – both
clinical and practical.  Submissions are welcome and
encouraged.  It’s your forum for communication!
Types of submissions include:
1. Viewpoint:  Brief statement on a controversial topic
(maximum 400 words).
2. Case Report
3. Review articles (maximum 1000 words)
4. Letter to the Editor:  Response to published article
5. Original research
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July 2000 will always be perhaps a special moment for
CAL/AAEM. We are now moving forward with the first issue of
our newsletter: the California Journal of Emergency Medicine. In
less than two years and with only 200 California AAEM members,
we have organized so far 3 successful widely-publicized Business
Forums on critically important practice issues in emergency
medicine (EM). We have supported emergency physicians (EPs)
in their legal struggles for due process. We have recruited an
impressive panel of EPs to our board of directors and to the
leadership of almost every committee.
Perhaps our most important effort has been in our opposition
to the “Corporatization of EM” by publicly held and hospital
owned entities. We have targeted “Exit Strategies” as our most
important priority due its critically damaging impact on the
welfare of the majority of EPs. CAL/AAEM stood unequivocally
united with the CMA, ACHP and our own AAEM in supporting
nearly 40 EP groups in their struggle to stand against what we
believe is a dangerous violation of the California laws prohibiting
the corporate practice of medicine by non-physician entities. We
are also actively progressing in our work with the State Medical
Board to address the issue of moonlighting while emphasizing the
value of board certification in EM as a requirement for the
independent practice of EM. Our patients deserve nothing less.
I would like to dedicate the first issue of our newsletter and
my first CAL/AAEM President’s message to CAL/ACEP. As EPs,
united, we must all express our gratitude to CAL/ACEP for its
long-standing dedication and its achievements on a state and
national level. We also wish to thank its members and its current
past and current leadership for the outstanding services
CAL/ACEP has provided to all EPs on nearly every front. You
equally touch the lives of your members and non-members.
Many of our members and readers will next ask “Then why a
second state organization?” Why not maintain a cohesive one-
organization approach in California? Why even join CAL/AAEM?
Those are indeed most legitimate questions. A second
“organized EM voice” in California certainly carries the risk of
weakening our efforts. It could be labeled as “divisive” and
demoralizing. Why not simply participate and contribute
effectively to a more resourceful experienced organization?
Furthermore, CAL/ACEP is actually an organization that has
recently embraced our participation. In June 2000, its members
have elected three of our AAEM leaders to its own board of
directors.  CAL/ACEP has enriched us with many of our own
AAEM members who are dual in their affiliations, including 3 of
its own past Presidents. Even the EMPAC Board has at least 3 of
our own AAEM members.
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Clinical Review
Phenobarbital for Alcohol Withdrawal:  Rapid Patient Disposition
John R. Richards, M.D.
U.C. Davis School of Medicine
For thousands of years, ethanol abuse continues to be a serious
problem worldwide.  Emergency physicians face the consequences of
alcoholism.  Chronic alcoholics often present to the emergency
department with seizures, ketoacidosis, and symptoms of withdrawal.
These patients require significant physician time, nursing, and medical
resources. For sedation and reversal of withdrawal symptoms,
benzodiazepines (BZDs) have most commonly been utilized in the
(ED) and intensive care unit setting.  Phenobarbital is an older drug that
is perhaps currently underutilized for alcohol withdrawal. In this article
I will discuss the advantages of phenobarbital over BZDs in the rapid
disposition of chronic alcoholic patients.
The pharmacologic action of the diminutive ethanol molecule is
complex. It is believed to increase the fluidity of the lipid bilayer of cell
membranes within the central nervous system, resulting in alteration of
membrane function from diminished viscosity.  One example of this is
the enhanced action of the inhibitory neurotransmitters GABA and
glutamate at their respective receptors in the presence of ethanol.
Ethanol also appears to affect opioid receptors, as well as many other
membrane-bound enzymes and ion channels.
A variety of pharmacologic agents have been tried in the past for
withdrawal. Besides BZDs and phenobarbital, other anticonvulsants,
such as phenytoin, have been used with limited success. Phenytoin has
little efficacy in the mitigation of withdrawal symptoms, and does
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Overcrowding (cont.)
3. Violence.  Tempers flare and a few patients tend to become
more agitated and violent in crowded conditions.  Instances of
violence have occurred in various ED waiting rooms over
who is to be seen first, creating a hostile atmosphere.   Bodily
harm has occurred to both nursing staff and emergency
physicians.
4. Lost “Golden Hour.”  Bad outcome have resulted from
overcrowded conditions.  Patients with subtle presentations of
serious diseases such as MI, PE, rupturing aortic aneurysms,
ectopic pregnancy, or stroke may miss the “golden hour” of
effective treatment waiting on a gurney in the hallway.
Additionally, patients with serious infections such as sepsis,
pneumonia or meningitis may experience delays which result
in bad outcome.  I am aware of a patient who sat in an ER
waiting room for four hours with Fournier’s Gangrene, and as
a result had a bad outcome.  As physicians are seeing more
complex and acutely ill patients, some feel they do not have
adequate time to thoroughly evaluate each patient.
5. Ambulance diversions.  Ambulance diversion has increased
both in urban and suburban areas.  The consequences of these
diversions include significantly increased transport times, risk
of traffic accidents en route, and potential for poor clinical
outcome.
6. Increased errors in treatment. Feeling rushed and under time
pressure results in errors and risk for malpractice or legal
action.  Decision errors have resulted from
miscommunication during periods of overwhelming patient
volume.  With increasing numbers of patients, errors such as
mislabeled specimens or drug dosing also increase in
frequency.
The problem of overcrowding in EDs will not improve until
hospitals invest money to improve service.  EM physicians need to
be active and vocal at the local, state, and national levels and
demand legislation aimed at improving the overcrowding problem.
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Clinical Review (cont.)
appear to have a role in prevention of seizures from head injury in the
alcoholic patient. Phenothiazines and butyrophenones are generally
thought to increase risk of seizure in this subgroup, but no studies have
demonstrated this specifically.  These drugs appear to have little effect
on the GABA receptor, and are rarely selected as first-line agents.
BZDs, which first appeared in the 1950s, are the most commonly
used pharmacologic agents for alcohol withdrawal. These drugs are
GABA receptor agonists which increase the frequency of chloride
channel openings, and undergo hepatic metabolism exclusively.  The
half-life varies considerably between specific drugs, and depends on
lipid solubility and activity of specific metabolites. Longer acting
BZDs (half-life 20-80 hours) such as diazepam and chlordiazepoxide
tend to be more lipid soluble and require less frequent dosing after
discharge from the emergency department from auto-tapering.
However, the lipid-soluble metabolites, such as nordiazepam, tend to
accumulate over time. This may be a problem for patients with
compromised hepatic function, which chronic alcoholics tend to have.
The shorter acting agents (half-life 2-20 hours) such as lorazepam and
triazolam are converted into water-soluble metabolites that are quickly
excreted by the kidneys.
Phenobarbital, first synthesized in 1912, has been used in the past
for alcohol withdrawal but has fallen out of favor, as BZDs have
become more widely used and have a putative greater margin of safety.
The exact mechanism of barbiturates is unclear, but it is known that
barbiturates bind to the GABA receptor and increase the duration of
chloride channel opening. This is in contrast to BZDs, which increase
the frequency of openings. This may in part explain the need for more
frequent dosing of BZDs compared to phenobarbital.(4) Phenobarbital
also enhances the activity of the microsomal ethanol oxidizing system,
which aids in the metabolism of ethanol. The metabolites of
phenobarbital are inactive, and the drug is eliminated very slowly by
the liver. The half-life for phenobarbital can be up to 5 days, making it
ideal for outpatient disposition from the emergency department.
Patients presenting with uncomplicated alcohol withdrawal, with
perhaps seizures and mild to moderate tremor, may be candidates for
outpatient treatment and disposition. For clinicians selecting a BZD, it
is often necessary to give multiple doses before adequate sedation is
achieved. This requires more time and attention from the emergency
physician in the reassessment of the situation. These patients may
respond well to administration of BZDs in the ED and, because of the
limited half-life, will require a prescription for more of the drug to
prevent relapse. This places the burden of filling the prescription and
taking the pills at the proper time intervals on the patient. Often this is
too much responsibility for the chronic alcoholic.
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Landmark Trial Starts
By Howard Davis, MD, FAAEM, FACEP
    June 30, 2000, marked an historic day for the specialty of
Emergency Medicine. On that day, ACHP (Affiliated Community
Healthcare Physicians) submitted its trial documents in the case of
ACHP v. CHW (Catholic Healthcare West). With the support of
the American Academy of Emergency Medicine, the California
Medical Association, the California Society of Anesthesiologists,
the California Radiology Society and the California Society of
Pathologists, a group of practicing Emergency Physicians (EPs)
and other Hospital Based Physicians has taken on a multibillion
dollar hospital corporation. The trial may last through the summer and
into the fall.
    For those unfamiliar with the case, a brief summary follows: In
October of 1997 CHW announced the purchase of  “the management
arm” of EPMG (Emergency Physicians Medical Group). The purchase
price was $40 million and I believe most of this went to a handful of
top shareholders. The working EPs in EPMG, many of whom received
nothing from this purchase, were tied to this management arm
(renamed “Meriten”) by a thirty-year contract which provided a thirty-
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